"Welcome to SSJ Finance"

Profit & Loss Accounts

Quarterly Results

Mankind Pharma Ltd
Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln	Chairman : RAMESH CHAND JUNEJA
Home : Indian Private	Book Value: 354.6937544
BSE Code : 543904	Market Cap: 106485.5
NSE Code : MANKIND	P / E : 58.85

Change Company :

Quarters:

(Rs in Cr.)

Quarterly Results

Particulars	Jun 2025	Mar 2025	Dec 2024	Sep 2024
Type	1Qtr	4Qtr	3Qtr	2Qtr
Net Sales	2541.36	2126.59	2414.41	2529.74
Other Income	64.22	219.32	70.37	137.75
Total Income	2605.58	2345.91	2484.78	2667.49
Total Expenditure	1868.29	1649.67	1668.31	1777.71
Operating Profit	737.29	696.24	816.47	889.78
Interest	146.70	162.25	200.27	1.92
Gross Profit	590.59	533.99	616.20	887.86
Depreciation	96.93	105.24	91.11	85.42
Tax	92.14	93.07	135.85	131.23
Deferred Tax	-11.24	-46.78	-22.78	36.78
Reported Profit After Tax	412.76	382.46	412.02	634.43

SSJ FINANCE & SECURITIES PRIVATE LIMITED:
1st Floor, Merchant Chamber, Opp. Patkar Hall, 41, New Marine Lines, Mumbai – 400 020
SEBI Regn. Number: INZ000178436 | CDSL: IN-DP-109-2015 | ARN: 40860 | CIN: U67120MH1996PTC104822

SSJ COMMODITIES PRIVATE LIMITED:
SEBI Regn. Number: INZ000013439 | CIN: U51909MH2003PTC140481|Research Analyst SEBI Reg. No.INH000001527

Content powered by Capital Market Charts are powered by TradingView